Columbia-Suicide Severity Rating Scale Screen Version: initial screening for suicide risk in a psychiatric emergency department.
Receiver operating characteristic curves
risk assessment
screening
suicide
Journal
Psychological medicine
ISSN: 1469-8978
Titre abrégé: Psychol Med
Pays: England
ID NLM: 1254142
Informations de publication
Date de publication:
26 Mar 2021
26 Mar 2021
Historique:
entrez:
26
3
2021
pubmed:
27
3
2021
medline:
27
3
2021
Statut:
aheadofprint
Résumé
Suicide screening is routine practice in psychiatric emergency (PE) departments, but evidence for screening instruments is sparse. Improved identification of nascent suicide risk is important for suicide prevention. The aim of the current study was to evaluate the association between the novel Colombia Suicide Severity Rating Scale Screen Version (C-SSRS Screen) and subsequent clinical management and suicide within 1 week, 1 month and 1 year from screening. Consecutive patients (N = 18 684) attending a PE department in Stockholm, Sweden between 1 May 2016 and 31 December 2017 were assessed with the C-SSRS Screen. All patients (52.1% women; mean age = 39.7, s.d. = 16.9) were followed-up in the National Cause of Death Register. Logistic regression and receiver operating characteristic curves analyses were conducted. Optimal cut-offs and accuracy statistics were calculated. Both suicidal ideation and behaviour were prevalent at screening. In total, 107 patients died by suicide during follow-up. Both C-SSRS Screen Ideation Severity and Behaviour Scales were associated with death by suicide within 1-week, 1-month and 1-year follow-up. The optimal cut-off for the ideation severity scale was associated with at least four times the odds of dying by suicide within 1 week (adjusted OR 4.7, 95% confidence interval 1.5-14.8). Both scales were also associated with short-term clinical management. The C-SSRS Screen may be feasible to use in the actual management setting as an initial step before the clinical assessment of suicide risk. Future research may investigate the utility of combining the C-SSRS Screen with a more thorough assessment.
Sections du résumé
BACKGROUND
BACKGROUND
Suicide screening is routine practice in psychiatric emergency (PE) departments, but evidence for screening instruments is sparse. Improved identification of nascent suicide risk is important for suicide prevention. The aim of the current study was to evaluate the association between the novel Colombia Suicide Severity Rating Scale Screen Version (C-SSRS Screen) and subsequent clinical management and suicide within 1 week, 1 month and 1 year from screening.
METHODS
METHODS
Consecutive patients (N = 18 684) attending a PE department in Stockholm, Sweden between 1 May 2016 and 31 December 2017 were assessed with the C-SSRS Screen. All patients (52.1% women; mean age = 39.7, s.d. = 16.9) were followed-up in the National Cause of Death Register. Logistic regression and receiver operating characteristic curves analyses were conducted. Optimal cut-offs and accuracy statistics were calculated.
RESULTS
RESULTS
Both suicidal ideation and behaviour were prevalent at screening. In total, 107 patients died by suicide during follow-up. Both C-SSRS Screen Ideation Severity and Behaviour Scales were associated with death by suicide within 1-week, 1-month and 1-year follow-up. The optimal cut-off for the ideation severity scale was associated with at least four times the odds of dying by suicide within 1 week (adjusted OR 4.7, 95% confidence interval 1.5-14.8). Both scales were also associated with short-term clinical management.
CONCLUSIONS
CONCLUSIONS
The C-SSRS Screen may be feasible to use in the actual management setting as an initial step before the clinical assessment of suicide risk. Future research may investigate the utility of combining the C-SSRS Screen with a more thorough assessment.
Identifiants
pubmed: 33766155
doi: 10.1017/S0033291721000751
pii: S0033291721000751
pmc: PMC9811343
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-9Références
JAMA Netw Open. 2020 Apr 1;3(4):e203933
pubmed: 32343354
Am J Psychiatry. 2011 Dec;168(12):1266-77
pubmed: 22193671
Psychol Med. 1997 Mar;27(2):467-72
pubmed: 9089838
Psychol Med. 2018 May;48(7):1119-1127
pubmed: 28874218
JAMA Psychiatry. 2018 Sep 1;75(9):894-900
pubmed: 29998307
BMJ. 2010 Jul 13;341:c3222
pubmed: 20627975
Lancet Psychiatry. 2016 Jul;3(7):646-59
pubmed: 27289303
Pediatr Emerg Care. 2015 Feb;31(2):88-94
pubmed: 25285389
Stat Med. 2011 Nov 20;30(26):3149-61
pubmed: 22025311
Am J Psychiatry. 2017 Aug 1;174(8):765-774
pubmed: 28320225
J Clin Psychiatry. 2016 Jul;77(7):e867-73
pubmed: 27464320
Suicide Life Threat Behav. 2020 Feb;50(1):111-121
pubmed: 31441952
N Engl J Med. 2020 Jan 16;382(3):266-274
pubmed: 31940700
Br J Psychiatry. 2017 Jun;210(6):387-395
pubmed: 28302700
Psychiatr Serv. 2020 Feb 1;71(2):205-208
pubmed: 31795855
Lancet Psychiatry. 2019 Jul;6(7):582-589
pubmed: 31171451
BMJ Open. 2016 Sep 27;6(9):e011929
pubmed: 27678536
Evid Based Ment Health. 2019 Aug;22(3):125-128
pubmed: 31248976
Lancet Digit Health. 2020 Jan;2(1):e25-e36
pubmed: 33328037
J Clin Psychiatry. 2016 Feb;77(2):240-6
pubmed: 26301588
PLoS Med. 2016 Mar 01;13(3):e1001968
pubmed: 26930055
PLoS One. 2017 Jul 19;12(7):e0180292
pubmed: 28723978
Suicidologi. 2018;23(1):22-30
pubmed: 29970972
BMC Psychiatry. 2018 Oct 1;18(1):319
pubmed: 30285661
Int J Methods Psychiatr Res. 2011 Mar;20(1):40-9
pubmed: 21499542
Front Psychiatry. 2018 Feb 23;9:33
pubmed: 29527178
Am J Prev Med. 2016 Apr;50(4):445-453
pubmed: 26654691
BMJ. 2019 Feb 6;364:l94
pubmed: 31339847
Br J Psychiatry. 2020 Dec;217(6):659-660
pubmed: 32228741
JAMA Psychiatry. 2020 Sep 1;77(9):885-886
pubmed: 32432690
JAMA Psychiatry. 2017 May 1;74(5):485-492
pubmed: 28296989
Am J Psychiatry. 2017 Feb 1;174(2):154-162
pubmed: 27609239
BMJ. 2011 Nov 23;343:d7073
pubmed: 22113565
J Clin Epidemiol. 2008 May;61(5):517-8
pubmed: 18394548
EJIFCC. 2009 Jan 20;19(4):203-11
pubmed: 27683318
BMJ. 2015 Nov 09;351:h4978
pubmed: 26552947
Am J Psychiatry. 2018 Oct 1;175(10):951-960
pubmed: 29792051
BMJ Open. 2016 Feb 12;6(2):e009297
pubmed: 26873046
Br J Psychiatry. 2017 Sep;211(3):183
pubmed: 28864758
BMJ. 2017 Oct 17;359:j4627
pubmed: 29042363
Psychol Med. 2012 Nov;42(11):2383-94
pubmed: 22394511
JAMA Psychiatry. 2019 Jun 1;76(6):642-651
pubmed: 30865249
BMC Psychiatry. 2017 Mar 20;17(1):96
pubmed: 28320345